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Malaria inflammation by xanthine
oxidase-produced reactive oxygen species
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Abstract
Malaria is a highly inflammatory disease caused by Plasmodium
infection of host erythrocytes. However, the parasite does not
induce inflammatory cytokine responses in macrophages in vitro
and the source of inflammation in patients remains unclear. Here,
we identify oxidative stress, which is common in malaria, as an
effective trigger of the inflammatory activation of macrophages.
We observed that extracellular reactive oxygen species (ROS)
produced by xanthine oxidase (XO), an enzyme upregulated during
malaria, induce a strong inflammatory cytokine response in
primary human monocyte-derived macrophages. In malaria
patients, elevated plasma XO activity correlates with high levels of
inflammatory cytokines and with the development of cerebral
malaria. We found that incubation of macrophages with plasma
from these patients can induce a XO-dependent inflammatory
cytokine response, identifying a host factor as a trigger for
inflammation in malaria. XO-produced ROS also increase the
synthesis of pro-IL-1b, while the parasite activates caspase-1,
providing the two necessary signals for the activation of the NLRP3
inflammasome. We propose that XO-produced ROS are a key factor
for the trigger of inflammation during malaria.
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Introduction
Malaria induces an extremely high inflammatory response which,
coupled to the sequestration of Plasmodium falciparum-infected red
blood cells (iRBC), plays a key role in the life-threatening patholo-
gies associated with this disease (Clark, 2007; Clark et al, 2008). A
remarkable paradox in malaria research is that the strong inflamma-
tory cytokine response and high fevers in patients cannot be
modeled in vitro, where incubation of the parasite with immune
cells results in little to no response in immune cells, such as macro-
phages (Scragg et al, 1999; Couper et al, 2010; Zhou et al, 2012) or
dendritic cells (Elliott et al, 2007; Giusti et al, 2011; Go¨tz et al,
2017). It is important to note that older publications showing
in vitro inflammation were latter attributed to mycoplasma contami-
nation of the cultures (Rowe et al, 1998).
The levels of oxidative stress in the circulation of malaria
patients are elevated, as it is evident by the presence of high concen-
trations of plasma malondialdehyde, a by-product of lipid peroxida-
tion, that is indicative of elevated oxidative stress (Narsaria et al,
2012). There are several sources of oxidative stress described in
malaria: Plasmodium growth in erythrocytes (Atamna & Ginsburg,
1993), the macrophage oxidative burst (Kharazmi et al, 1987), and
the upregulation of oxidative enzymes in the host (Iwalokun et al,
2006). Although they can all generate reactive oxygen species (ROS)
during malaria, the relative contributions of each during infection
are not known.
Upregulation of xanthine oxidase (XO), a host oxidative enzyme,
has been documented in the circulation of malaria patients, infected
monkeys, and mice (Tubaro et al, 1980; Srivastava et al, 1992;
Siddiqi et al, 1999; Iwalokun et al, 2006). The enzyme precursor of
XO, xanthine dehydrogenase, is upregulated by activation of type
I IFN receptor very early upon Plasmodium infection in mice
(Guermonprez et al, 2013), suggesting that early sensing of malaria
results in increased oxidative stress.
In general, oxidative stress is known to cause inflammation
through the destruction of tissues and release of danger signals by
necrotic cells (Mittal et al, 2014). Here, we show an alternative
mechanism where oxidative stress directly activates human macro-
phages to release inflammatory cytokines, identifying extracellular
ROS a potent trigger of inflammation. In the context of malaria, we
found that an inflammatory cytokine response could be triggered in
macrophages simply by incubation with the plasma of malaria
patients and that this response is dependent on XO, since a specific
inhibitor of this enzyme can inhibit this response. These results
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implicate XO as a host-derived source of inflammation in malaria.
Accordingly, we observed that patients with elevated XO activity
also present high levels of plasma inflammatory cytokines and
higher incidence of cerebral malaria. We have also observed that
P. falciparum acts as signal 2 and synergizes with ROS which act as
signal 1 for the activation of the NLRP3 inflammasome and the
release of IL-1b by macrophages.
Results
To study the inflammatory response induced by P. falciparum, we
incubated iRBC in the late developmental schizont stage with
human macrophages derived from monocytes isolated from healthy
donors. Little to no inflammatory cytokines are produced by these
macrophages, which otherwise respond strongly to LPS (Fig 1A)
and are fully viable (Appendix Fig S1). Similar results were
observed when infected red blood cell lysates (iRBCL), which
presumably contain potential pathogen-associated molecular
patterns (PAMPs; Gazzinelli et al, 2014), were incubated with the
macrophages (Fig 1B). A wide range of ratios of macrophages to
iRBCL was tested in two independent experiments finding no detect-
able cytokine secretion at any concentration (Appendix Fig S2).
Priming of macrophages with IFNc (Fig 1C) or co-incubation with
IFNa (Appendix Fig S3) before addition of iRBC (Glass & Natoli,
2015) also does not result in inflammatory cytokine secretion. We
also observed that macrophages efficiently phagocytose iRBC
(Fig 1D) and that incubation of macrophages with iRBC does not
inhibit subsequent activation by LPS (Fig 1E), suggesting that the
iRBC do not induce permanent inhibition of macrophage activation.
Altogether, these data demonstrate that P. falciparum iRBC do not
induce secretion of inflammatory cytokines by human monocyte-
derived macrophages in vitro.
Malaria induces a “cytokine storm” in patients, where elevated
levels of cytokines are found in the bloodstream (Clark, 2007; Clark
et al, 2008). This is in contrast with our observations that P. falci-
parum does not induce even a minimal inflammatory cytokine
response in vitro and suggests that other factors must be involved in
triggering the host inflammatory response.
To study whether ROS, which are produced in large amounts
during malaria, could contribute to the activation of the immune
cells, we utilized XO, an enzyme involved in the oxidation of hypox-
anthine and a potent producer of ROS (Battelli et al, 2016). XO is
upregulated in children with malaria, and its levels increase with
disease severity (Iwalokun et al, 2006). We observed that incuba-
tion of human macrophages in vitro with XO at a typical concentra-
tion found in the plasma of patients infected with P. falciparum
(0.12 U/ml; Iwalokun et al, 2006) results in an increase of
inflammatory cytokine secretion comparable to the one induced by
LPS (Fig 2A). A dose–response analysis showed that increasing the
concentrations of XO results in increased cytokine secretion by
macrophages (Appendix Fig S4).
Increasing the concentration of hypoxanthine, the substrate for
XO, results in higher levels of cytokine secretion (Fig 2B), while
incubation with the specific inhibitor of XO febuxostat (Osada et al,
1993) results in decreased cytokine release (Fig 2C). These results
confirm the XO specificity of the observed response and exclude the
possibility that the cytokine secretion was caused by contamination
of the XO. Furthermore, inactivation of XO activity by heat treat-
ment and addition of anti-oxidants, either membrane permeant or
not, decreases cytokine secretion by macrophages incubated with
XO (Fig 2D), indicating that the inflammatory activity is mediated
by XO-produced ROS.
We also studied the response of whole peripheral blood mononu-
clear cells (PBMCs) to P. falciparum iRBC, whole or lysate, finding a
weak cytokine response which was not significantly different than
the RBC controls. PBMC also responded strongly to XO stimulation
(Fig 2E).
XO produces ROS in the form of superoxide, which rapidly
dismutates to H2O2 (Knowles et al, 1969) and permeates cell
membranes reaching the cytosol (Bienert et al, 2007). We observed
that cytokine secretion was not induced by the addition of H2O2
(Appendix Fig S5), which is short-lived within cells (Rhee et al,
2005). However, incubation of macrophages with XO for different
times revealed that cytokine secretion requires exposure to the
enzyme for at least 15 min (Fig 3A), suggesting that a prolonged
exposure to ROS is necessary for the activation of the inflammatory
response.
Since intracellular ROS are a well-characterized second messen-
ger in the signaling cascade for immune cell activation (Schieber &
Chandel, 2014), we next determined whether cytokine secretion
could be triggered strictly by extracellular ROS or if it required intra-
cellular production of these reactive molecules. We observed that
physical separation of XO from macrophages through a dialysis
membrane did not interfere with macrophage activation, indicating
that extracellular ROS can induce cytokine secretion in macrophages
(Fig 3B). These results expand the traditional view where activation
of toll-like receptors (TLRs) or cytokine receptors induce intracellu-
lar ROS that act as second messengers, resulting in NFkB-mediated
cytokine secretion (Nathan & Cunningham-Bussel, 2013).
To study the relevance of XO-produced ROS during P. falciparum
infection, we first determined the relation between oxidative stress
resulting from XO activity in the plasma of malaria patients and the
levels of inflammatory cytokines. XO activity was measured by
detecting ROS produced by plasma XO after addition of excess
concentrations of its substrate, hypoxanthine. Under these condi-
tions, the assay reflects the levels of oxidative stress produced by
XO that are not quenched by anti-oxidants in the plasma, providing
a measurement of the oxidant/anti-oxidant balance for each patient
sample. We observed that two cytokines, TNF and IL-8, showed a
significant correlation with plasma XO activity (Fig 4A), suggesting
an involvement of this enzyme in malaria-induced inflammation.
We also observed that patients with cerebral malaria showed higher
levels of XO activity compared to patients with uncomplicated
malaria (Fig 4B), suggesting a role for oxidative stress in the patho-
genesis of this complication.
To determine whether plasma XO in malaria patients is responsi-
ble for triggering an inflammatory response in macrophages, we
incubated plasma from malaria patients with macrophages in vitro.
We observed that plasma samples from malaria patients can induce
inflammatory cytokine secretion in macrophages that is inhibited by
febuxostat (Fig 4C), indicating that XO is required for the generation
of this response. Interestingly, the sample with higher levels of XO
activity (twofold increase over healthy control plasma samples)
corresponded to a patient with cerebral malaria and also induced a
higher inflammatory response in macrophages. The plasma from
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the two patients with uncomplicated malaria presented lower levels
of XO activity and inflammation in vitro. It is important to note that
no parasites or infected cells were added to this assay, suggesting
that at least part of the inflammatory response triggered during
malaria is not induced directly by the parasite.
Next, we investigated how oxidative stress contributes to
inflammation in the context of malaria, where macrophages are
simultaneously exposed to ROS and Plasmodium. We observed that
when macrophages are incubated with P. falciparum iRBCL in the
presence of XO, a synergistic increase is observed in the secretion of
IL-1b, but not of TNF, IL-6, or IL-10 (Fig 5A). Although iRBCL alone
did not induce secretion of IL-1b, it increased the secretion of this
cytokine in response to XO by 20-fold. This increase is specific of
iRBCL and dependent on its concentration (Fig 5B), indicating that
infected, but not uninfected, erythrocytes synergize with ROS lead-
ing to increased release of IL-1b. Co-incubation of macrophages with
XO and iRBCL also induced synergistic production of the chemoki-
nes IL-8, CCL5, and CCL2 (Fig 5C), which are essential in the
recruitment and activation of leukocytes to sites of inflammation
(Luster, 1998) and are also elevated during malaria (Ioannidis et al,
2014).
Elevated levels of IL-1b lead to inflammatory events such as
fever, increased circulating neutrophils, upregulation of surface
markers in cells, extensive nitric oxide production, and elevated
levels of CRP and inflammatory cytokines (Dinarello, 1996, 2009;
Cahill & Rogers, 2008), which are all common in malaria
(Mackintosh et al, 2004). We propose that elevated levels of IL-1b
induced by ROS contribute to the systemic inflammation in malaria.
The expression and release of IL-1b are mediated through the
standard two-checkpoint model of priming and activation (He et al,
2016). Priming, considered signal 1, is classically mediated by the
activation of TLRs, whose downstream signaling leads to the
translocation of NFjB and the production of pro-IL-1b. Activation,
or signal 2, promotes the assembly of a multimeric protein complex
called the inflammasome, culminating in the autocatalyzation of
caspase-1, the subsequent cleavage of pro-IL-1b, and the release of
bioactive IL-1b (Broz & Dixit, 2016). Gene expression analysis of
macrophages incubated with XO shows greatly augmented IL-1b
transcripts that are not much further increased when iRBCL are
added (Fig 6A). Detection of pro-IL-1b protein in macrophages
reveals that its presence is dependent on XO, but not on iRBCL
(Fig 6B), indicating that XO is acting as signal 1 in macrophages. In
contrast, activation of caspase-1 in macrophages is dependent on
iRBCL, but not on XO (Fig 6C), assigning the function of signal 2 to
iRBCL. This model is consistent with the synergistic increase in
IL-1b secretion that is observed after the addition of iRBCL to
XO-treated macrophages (Fig 5A and B). These data indicate that
priming of macrophages is achieved by exposure to extracellular
ROS, which promotes the production of pro-IL-1b, while the pres-
ence of infected erythrocytes mobilizes the inflammasome, propel-
ling to the activation of caspase-1 and the consequent cleavage and
release of bioactive IL-1b.
NLRP3 has consistently been implicated as a sensor for
inflammasome activation in monocytes from both P. falciparum
and Plasmodium vivax malaria patients (Ataide et al, 2014; Hirako
et al, 2015). To determine whether NLRP3 is the inflammasome
sensor molecule activated by P. falciparum in macrophages, we
transfected human monocyte-derived macrophages with siRNA to
knockdown expression of NLRP3. We achieved a 50% reduction
in NLRP3 mRNA expression (Appendix Fig S6). When NLRP3-
siRNA-transfected macrophages were incubated with both iRBCL
and XO, they fail to secrete IL-1b compared to cells transfected
with control siRNA (Fig 6D), implicating NLRP3 as the sensor that
recognizes the parasite and leads the formation of the inflamma-
some in human macrophages. Conversely, the levels of other
inflammatory cytokines and chemokines were not changed by
NLRP3-siRNA transfection (Appendix Fig S7), which suggests that
the increase observed in response to XO and iRBC stimulation
(Fig 5C) is independent of IL-1b. Taken together, these results
indicate that in human macrophages, extracellular ROS function as
a signal 1, triggering the production of pro-IL-1b, while Plasmod-
ium provides signal 2 for the activation of the NLRP3
◀ Figure 1. Plasmodium falciparum-infected erythrocytes do not induce inflammatory cytokine secretion in human monocyte-derived macrophages.A, B Macrophages produce little to no inflammatory cytokines when incubated with either (A) whole iRBC or (B) fresh iRBCL for 24 h. One-way ANOVA with Tukey test
for multiple comparisons was performed to determine statistical significance.
C Macrophages were pre-incubated with IFNc (1,000 U/ml) for 18 h before iRBCL stimulation. One-way ANOVA with Tukey test for multiple comparisons was
performed to determine statistical significance.
D Phase-contrast microscopy of macrophages 24 h after the addition of RBC, iRBC, or LPS. Dark hemozoin crystals can be observed within macrophages. Scale bar is
30 lm.
E Macrophages were incubated with iRBCL 24 h before addition of LPS. Paired t-test was performed to determine statistical significance.
Data information: Each symbol represents the value obtained for cells from an independent donor in an independent experiment. (A) n = 4; (B) n = 5; (C) n = 3;
(E) n = 3. Asterisks indicate significance (*P < 0.05, **P < 0.01, and ***P < 0.001) when values were compared with RBC (A–C) or RBCL (E).
Source data are available online for this figure.
▸Figure 2. Exposure to ROS promotes cytokine secretion from human macrophages and from PBMC.A–E Cytokine secretion of macrophages (A–D) or PBMC (E) incubated with the indicated stimuli for 24 h. RBC, iRBC, RBCL, iRBCL, XO, hypoxanthine (Hyx), the anti-
oxidants N-acetyl-L-cysteine (NAC), and 1-thioglycerol (1-TG), and heat inactivated (HI) XO were added to macrophages for 24 h. Febuxostat (Feb) was pre-
incubated for 30 min with XO before addition to macrophages. Each symbol represents the value obtained for cells from an independent donor in an independent
experiment. Insets show paired samples by donor in two different conditions. Blue asterisks indicate significance when values were compared with RBCL (A, E) or
XO (B–D). Gray asterisks mark comparison with control (B–D). (A) n = 7; (B–E) n = 3. One-way ANOVA with Tukey test for multiple comparisons was performed to
determine statistical significance (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).
Source data are available online for this figure.
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inflammasome, resulting in the activation of caspase-1, which
cleaves pro-IL-1b into mature IL-1b (Fig 6E).
Discussion
Since the host inflammatory response contributes decisively to the
pathology caused by Plasmodium infection (Mackintosh et al,
2004), understanding the mechanisms causing inflammation in
malaria is of crucial importance. However, progress has been
hindered by the lack of an in vitro model of inflammation since
incubation of the parasite with macrophages or dendritic cells
results in little to no response (Scragg et al, 1999; Elliott et al, 2007;
Couper et al, 2010; Giusti et al, 2011; Zhou et al, 2012). Although
PBMC incubation with iRBC results in detectable cytokine
responses, which have been previously attributed mainly to mono-
cytes and cd-T cells (D’Ombrain et al, 2008; Stanisic et al, 2014),
we found that they were not statistically significant and much lower
than the responses observed to LPS. Several pathogen-associated
molecular patterns have been identified in P. falciparum, including
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Figure 3. Prolonged exposure to extracellular ROS induces cytokine secretion.
A XO was incubated with macrophages for the indicated times, when wells were washed twice and media was replaced. Supernatants were collected for cytokine
determinations 24 h later (n = 3). Error bars show standard deviation. Kruskal–Wallis statistical method was used for statistical analysis. Blue asterisks indicate
significance when values were compared with time 0 (*P < 0.05).
B Diagram shows experimental set up with macrophages in the bottom of the well and XO added either in the dialysis cassette (DC, blue) or the well (black). XO activity
panels show that the enzyme did not leak through the DC membrane. Secretion of IL-6 and TNF was measured 24 h after addition of XO in each compartment. A
representative result of two independent experiments is shown.
Source data are available online for this figure.
▸Figure 4. XO inflammatory activity in malaria patients and relation to cerebral malaria.A Plasma levels of TNF and IL-8 from patients with uncomplicated (black circles, n = 14) or cerebral (red circles, n = 9) malaria correlate with levels of XO-produced
ROS detected in each sample. ROS is expressed as fold change over plasma from healthy controls. Uncomplicated malaria, gray circles, cerebral malaria, red circles.
B Levels of XO activity in malaria patients correlate with disease severity UM (uncomplicated malaria, n = 14) and CM (cerebral malaria, n = 9). Error bars show
standard deviation.
C Plasma from malaria patients induces macrophages to secrete cytokines, which are inhibited by a XO-specific inhibitor. Plasma from a healthy control (HP) and from
three patients: P1 (with cerebral malaria), P2, and P3 (both with uncomplicated malaria), was pre-incubated for 30 min with febuxostat (Feb) or alone at 37°C before
addition to macrophages at 1:2 dilution in media for 30 min. Cells were washed and cytokine secretion measured in triplicates after 24 h of incubation.
Data information: Linear regression (A), Mann–Whitney test (B), and unpaired t-tests (C) were performed to determine statistical significance (*P < 0.05, **P < 0.01).
Source data are available online for this figure.
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GPI anchors, hemozoin, and parasite DNA (Gazzinelli et al, 2014).
When purified from iRBC, these molecules are able to induce
inflammatory cytokine responses from immune cells in vitro
(Gazzinelli et al, 2014); however, these in vitro assays frequently
use high concentrations of purified molecules that do not corre-
spond to physiological concentrations of parasite and a direct
comparison of purified molecules and whole iRBC or iRBCL were
not performed. It is also possible that whole parasites are able to
inhibit specific responses by these active molecules. Their relative
contribution to malaria-induced inflammation and pathology in
patients remains unclear (Erdman et al, 2008).
Considering the strong inflammatory responses observed in
malaria patients, other factors beyond the parasite and infected
erythrocytes must be involved in triggering the host inflammatory
response. Our results point to oxidative stress, and in particular,
extracellular ROS, as a trigger of inflammation in malaria since they
are abundantly produced during infection and, as we describe here,
are potent inducers of inflammatory cytokines.
An important role for oxidative stress in malaria-induced
inflammation in vivo was suggested by a clinical trial to test the
effect of allopurinol, an inhibitor of XO, in malaria. When treated
with allopurinol in addition to a classical anti-malarial drug, severe
malaria patients did not show significant improvement and only a
small decrease in parasite levels (P < 0.02). However, a much faster
decrease in inflammation [measured as fever (P < 0.0002) and sple-
nomegaly (P < 0.0002)] was reported when compared to patients
treated with the anti-malarial alone (Sarma et al, 1998), indicating
that inhibition of XO has a strong inhibitory effect in malaria
inflammation.
Our results where high levels of XO activity correlate with
inflammatory cytokines support the hypothesis that oxidation
induced by XO is an important cause of inflammation in malaria
patients. It should be noted that the levels of anti-oxidants in the
plasma will also influence the levels of active ROS in patients and
therefore the levels of inflammation. In our assay, the levels of XO
were measured as ROS activity detected after incubation with XO
substrate, hypoxanthine; therefore, the ROS-neutralizing effect of
the plasma anti-oxidants influences the final ROS levels detected in
every sample.
Additionally, we observed that higher levels of XO activity are
found in patients with cerebral malaria supporting the hypothesis
that oxidative stress is involved in the pathogenesis of this compli-
cation (Becker et al, 2004).
Our results where the plasma of some malaria patients triggered
febuxostat-sensitive inflammatory cytokine responses in macro-
phages suggest an important role for XO in the generation of the
inflammatory response to malaria. Although a higher number of
patient samples will be needed to confirm this trend, the inflamma-
tory activity of plasma from malaria patients already points to an
important contribution of host-derived XO in the generation of the
cytokine response. It is well-known that oxidative stress is associ-
ated with severity in malaria (Das et al, 1991; Greve et al, 2000;
Narsaria et al, 2012), an effect that may be mediated indirectly
through the ROS-induced elevated inflammatory reaction described
here and/or directly through detrimental effects of oxidative stress
in the tissues (Hemmer et al, 2005; Taoufiq et al, 2006).
Together with the observation that in the absence of ROS, human
monocyte-derived macrophages produce little to no cytokines when
they encounter infected erythrocytes or their lysates, these findings
may explain puzzling observations in asymptomatic malaria
patients, where detectable, or even high levels of parasites do not
induce any fever (Bousema et al, 2014). This suggests that ROS may
be pivotal for the inflammatory activation of immune cells, with the
parasite having an adjunctive role for the induction of IL-1b and
fever.
In this scenario, the upregulation of XO by type I IFN early in
infection (Guermonprez et al, 2013) would be critical to induce the
inflammatory response through the production of extracellular ROS.
Since oxidative stress is linked to malaria severity (Das et al, 1991;
Greve et al, 2000; Narsaria et al, 2012), this may explain the
improved clinical symptoms observed when IFNAR1 is deficient or
blocked in mice (Haque et al, 2014) and the link of specific SNPs in
IFNAR1 to cerebral malaria resistance in patients (Aucan et al,
2003).
◀ Figure 5. ROS and Plasmodium falciparum-infected erythrocytes generate synergistic secretion of IL-1b and chemokines.A–C Cytokine and chemokine secretion by macrophages after 24 h incubation with the indicated stimuli. (B) IL-1b levels after addition of increasing concentration of
RBCL or iRBCL (1:2, 1:4, and 1:8 macrophage:iRBCL). One-way ANOVA with Tukey test for multiple comparisons was performed to determine statistical significance.
Asterisks indicate significance when values are compared with XO + RBCL (*P < 0.05 and ***P < 0.001). Each symbol represents the value obtained for cells from
an independent donor in an independent experiment. (A) n = 4; (B) n = 2; (C) n = 4. Insets show paired samples by donor in two different conditions.
Source data are available online for this figure.
▸Figure 6. ROS prime macrophages for Plasmodium falciparum-infected erythrocytes activation of the NLRP3 inflammasome.A Gene expression analysis of macrophages incubated with the indicated stimuli expressed as fold change over RBCL. Dotted red line indicates 2-fold increase in RNA
expression.
B Western Blot analysis of pro-IL-1b. Relative abundance is the average of three independent experiments with different donors. Error bars show standard deviation.
C FLICA analysis of activated caspase-1. Results are representative of two independent experiments with different donors.
D Two distinct siRNAs against NLRP3 and an irrelevant control siRNA were utilized to knock down RNA levels by lipofectamine transfection in macrophages that were
later incubated with iRBCL, or RBCL as control, with or without XO, before quantification of secreted IL-1b. Results are representative of two independent
experiments with different donors.
E Diagram of macrophage inflammasome activation by XO and iRBC.
Source data are available online for this figure.
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In addition to elevated levels of host oxidative enzymes, such
as XO, ROS in malaria may also be induced by the oxidative
burst in macrophages that have phagocytosed iRBC (Ockenhouse
et al, 1984; Kharazmi et al, 1987; Golenser et al, 1992) and the
release of free heme from iRBC following synchronous schizont
rupture (Andrade et al, 2010; Gozzelino et al, 2012). Although
the relative contribution of these mechanisms in generating the
high level of oxidative stress that is observed in malaria patients
is not known, it is likely that they all contribute to the
inflammatory response since they all result in the production of
extracellular ROS. In particular, free heme has been implicated
in the inflammatory response in malaria in vivo (Pamplona et al,
2007).
Previous reports have identified that Plasmodium infection acti-
vates the inflammasome in human patients (Ataide et al, 2014;
Hirako et al, 2015); however, studies in vitro needed an additional
exogenous signal 1 for the production of IL-1b that was added in the
form of LPS, which is a bacterial product not present during malaria
(Ataide et al, 2014; Kalantari et al, 2014; Hirako et al, 2015). Our
results identify extracellular ROS, which are characteristic of malar-
ia, as an effective signal 1 for the activation of the inflammasome in
macrophages and provide a physiological explanation for those
previous observations.
High levels of ROS are produced in a large number of infectious
(Ivanov et al, 2017) and non-infectious diseases (Moylan & Reid,
2007; King, 2008; Reuter et al, 2010), but traditionally are consid-
ered intracellular messengers of inflammation, which are triggered
in response to PAMPs, damage-associated molecular patterns
(DAMPs), or cytokines (Nathan & Cunningham-Bussel, 2013; Broz
& Dixit, 2016). During infections, intracellular ROS are generated by
immune cells for killing of microbes through the oxidative burst
(Warnatsch et al, 2017). Here, we propose a new role for extracellu-
lar ROS in directly inducing inflammatory cytokine secretion and
synergizing with an infectious pathogen to activate the inflamma-
some in macrophages. Inhibition of this pathway through ROS inhi-
bition or neutralization may have important implications for
therapeutic use in diseases where inflammation triggered by oxida-
tive stress contributes to the pathology.
Materials and Methods
Parasite culture and isolation
Plasmodium falciparum 3D7 asexual stage was cultured in RPMI
1640 with 25 mM HEPES, 25 mM sodium bicarbonate, and 1%
gentamycin and enriched with 0.5% Albumax (pH 6.75) and
250 lM hypoxanthine. Parasitemias were measured every other day
by counting Giemsa (Sigma) stained blood smears, and cultures
were maintained at less than 5% parasitemia. Flasks were kept at
37°C, under atmospheric conditions (5% oxygen, 5% carbon diox-
ide, and 90% nitrogen). To retain synchronous cultures, parasite
growth was treated with 5% D-sorbitol, which lyses late-stage iRBC
leaving only ring stages. For experiments, schizont isolation was
achieved using MACS cell separation LS columns (Miltenyi Biotec)
and stored in 80°C. Mycoplasma contamination was assayed
monthly using the MycoAlert Mycoplasma Detection Kit (Lonza)
and found to be consistently negative.
Parasite lysate preparation
As a control, RBC were processed in parallel with iRBC and kept in
volumes of 100 ll or less. Quickly, 10 freeze–thaw cycles (5 s
freeze: 1 min thaw) were performed between liquid nitrogen and
the 37°C water bath. After the last cycle, the lysates were immedi-
ately added to the experimental plate.
Human cell isolation and differentiation
Fresh whole blood was isolated from healthy donors at the NYU
blood bank or Clinical and Translation Institute (CTSI) of NYU
School of Medicine in accordance with the guidelines established by
the NYU School of Medicine Institutional Review Board (IRB). Ster-
ile filtered 7.22% sodium citrate (Sigma) was mixed with 450 ml of
peripheral venous blood kept in constant agitation to avoid coagula-
tion. Isolation and enrichment of peripheral blood monocytes were
performed by density gradient centrifugation utilizing 30% Ficoll-
Paque PLUS (GE Life Sciences). Next, PBMCs were allowed to attach
to tissue culture plates (Falcon) and washed after 2 h, so only
strongly adherent monocytes were left. After an overnight incuba-
tion, isolated monocytes were plated in 24 wells at a concentration
of 500,000 cells/well in DMEM (Corning) and 1% Penicillin, Strep-
tomycin, and Glutamine mixture (PSG). Cells differentiated for
7–12 days in 10% Human Sera (Valley Biomedical).
Macrophage and Plasmodium falciparum co-cultures
Macrophage experiments were performed in 24-well plates in DMEM
(Corning) 10% human sera and 1% PSG in the presence or absence of
0.12 U/ml xanthine oxidase (from bovine milk; Sigma) and 1 lg/ml
LPS (Sigma). RBCLs and iRBCL were added at a 1:8 ratio (macro-
phage: RBC/iRBC). Twenty-four hours after experiments, super-
natants were obtained and stored at80°C unless otherwise noted.
XO heat inactivation
XO at a concentration of 1.2 U was mixed with 100 ll of DMEM,
heat inactivated at 95°C for 5 min, and immediately added to wells
to a final concentration of 0.12 U/ml.
Measurement of XO activity
XO activity was measured using Amplex Red Xanthine/Xanthine
Oxidase Assay Kit (Life Technologies) to detect ROS formation
following manufacturer’s instructions. A plate reader (Victor X3;
Perkin Elmer) was utilized for measuring reactions with fluorescent
excitation at 530 nm and emission at 590 nm. Background values
were subtracted during the analysis. XO production of ROS was con-
firmed for each batch of the commercial enzyme (Sigma). In the
experiment with human samples, the average of determinations on
three healthy control samples was used as negative control and
reference for XO activity in plasma samples.
Cytokine and chemokine measurements
Supernatants collected from experiments and plasma samples were
stored at 80°C. Inflammatory cytokines (IL-1b, IL-10, IL-6, and TNF)
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and chemokines (IL-8, CCL5, CXCL9, and CCL2) were quantified using
Cytometric Bead Array (CBA, BD Biosciences) and performed on
FACS Calibur (BD Biosciences) according to manufacturer’s protocol.
The limit of detection for each cytokine or chemokine was lower than
10 pg/ml. FCAP array (BD Biosciences) and FlowJo (TreeStar) were
utilized for quantification and further analysis.
Quantitative RT–PCR
Macrophages were isolated and differentiated as described above
and then incubated with iRBCL at a ratio of 1:8 for 6 h. RNeasy
Plus Mini Kit (Qiagen) was used for RNA extraction, and RT2 First
Strand kit (Qiagen) was utilized for subsequent cDNA synthesis
following manufacturer’s instructions. Analysis for macrophage
gene expression was analyzed using RT2 Profiler PCR Array Human
Innate and Adaptive Immune Responses (Qiagen).
Western blot analysis
Human monocyte-derived macrophages were washed 2× with 1× PBS
(Fisher) and stored in 80°C until further analysis. Frozen cell lysates
were washed, and lysis buffer comprised of RIPA buffer with protease
inhibitor; PMSF (Sigma) was added to the wells to obtain cell lysates.
After which, cell lysates were equalized for loading into a gradient
SDS–PAGE gels (Bio-Rad) using the BCA Protein Assay Kit (Pierce).
Proteins were separated by Tris–Hcl gel electrophoresis (Bio-Rad) and
transferred onto PVDF membranes (Bio-Rad). Later, membranes were
blocked overnight with blocking buffer (5% milk in 1× PBS-T with
0.1% Tween-20). For primary incubation, antibodies against IL-1b
and b-actin (Appendix Table S1) were incubated for an hour, followed
by another 1-h incubation with HRP-coupled secondary antibody
1:2,000 (Cell Signaling). Membranes were developed using Amer-
sham ECL Western Blotting Detection Reagents (GE Healthcare)
following manufacturer’s instructions. Quantification of protein band
density was performed using ImageJ (NIH) and normalized to b-actin.
siRNA transfections and knockdowns
Cells were isolated and differentiated as described above without
antibiotics. Once majority of cells are attached (70–90%) exhibit-
ing roundish macrophage/myeloid morphology (around day 4–5),
cells were deemed ready for transfection. Media was aspirated
gently from each well and washed twice with warm DMEM to
ensure removal of floating cells. Fresh DMEM was added to a final
volume of 250 ll and kept at 37°C with 5% CO2. While incubat-
ing, 3% vol/vol of HiPerfect transfection (Qiagen) was mixed with
200 nM of NLRP3 siRNA (HS CIAS1-6 and HS CIAS1-9, Qiagen) or
negative control siRNA (AllStars Negative Control, Qiagen) and
allowed to form complexes for 20 min at room temperature. After
which, the complexes were added in a dropwise manner and kept
without any serum at 37°C with 5% CO2. After 6 h, 500 ll of
DMEM with 10% human serum was added and incubated over-
night. Depending on the donor, another round of transfection was
repeated after 24 h. To test for the levels of NLRP3 mRNA, we
performed quantitative RT–PCR using RNeasy Plus Mini Kit
(Qiagen) and primers (TGAAGAAAGATTACCGTAAGAAGTACAGA
and GCGTTTGTTGAGGCTCACACT) for NLRP3 PCR amplification.
The internal normalizer gene used was 18sRNA with primers
CAGCCACCCGAGATTGAGCA and GCGTTTGTTGAGGCTCACACT
for PCR amplification.
Patients
Patients with cerebral malaria or uncomplicated P. falciparum
malaria were admitted to Ispat General Hospital in Rourkela, India,
from January 2012 to March 2014, as described elsewhere (Fernan-
dez-Arias et al, 2016). Blood samples were collected upon admission,
and plasma was frozen at 80°C for storage. 10% of the
plasma samples were shipped to New York University School of
Medicine for analysis, in accordance with the rules and regulations of
the Government of India. The parent study in India has approval for
the use of human subjects from the Institutional Review Boards from
the New York University School of Medicine, the London School of
Hygiene and Tropical Medicine, and from the Ispat General Hospital,
Rourkela, India. All studies involving human subjects were
conducted in accordance with the guidelines of the World Medical
Association’s Declaration of Helsinki. All individuals and/or their
legal guardians gave written informed consent. The clinical data and
samples were de-identified using a unique study number, in accor-
dance with the Health Insurance Portability and Accountability Act.
Patients include adults and children over the age of 5 of both
genders. All patients considered positive for cerebral malaria satisfied
a strict definition: coma (defined as Glasgow Coma Score > 9 out of 15
for adults and Blantyre Coma Score > 2 for children) after correction
of hypoglycemia (< 2.2 mmol/l), presenting asexual forms of P. falci-
parum in a peripheral blood smear sample, with or without associated
complications such as renal failure, severe anemia, and jaundice.
Plasma from three patients with malaria was used for Fig 4C: P1:
male, age 46, cerebral malaria, fatal; P2: male, age 52, uncomplicated
malaria, survived; P3: male, age 24, uncomplicated malaria, survived.
Patient’s plasma was diluted to 50% with DMEM and either left
untreated or pre-treated with 500 lM febuxostat (0.6% DMSO) for
30 min at 37°C, and the same concentration of DMSO was added to
control wells. Macrophages were then incubated with patient’s plasma
for 30 min, after which, cells were washed twice, and fresh DMEM
with 10% human sera and 1% PSG was added to cells. Supernatants
were collected 24 h later for cytokine quantification.
Statistical analysis
Statistical analysis of all data was accomplished using GraphPad Prism
7. D’Agostino-Pearson omnibus normality test was utilized to deter-
mine if data sets were normally distributed. Once normality was estab-
lished, one-way ANOVA was used as the statistical method with Tukey
test for multiple comparisons. For data that did not pass the test (not
normally distributed), Mann–Whitney, Wilcoxon, or Friedman test
paired with Dunn’s test for multiple comparison was used. Data were
considered significant if P < 0.05. Asterisks denote level of signifi-
cance: *P < 0.05, **P < 0.01, ***P < 0.001. Linear regression analysis
was used to analyze the relation of patient plasma cytokines and ROS.
Expanded View for this article is available online.
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The paper explained
Problem
Malaria is a highly inflammatory disease. While inflammation contri-
butes to eliminate the causative parasite, Plasmodium falciparum,
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